{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:32:44Z","timestamp":1788949964126,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00812","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T13:15:37Z","timestamp":1532524537000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Quantitative Evaluation of in Vivo Target Efficacy of Anti-tumor Agents via an Immunofluorescence and EdU Labeling Strategy"],"prefix":"10.3389","volume":"9","author":[{"given":"Yujun","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1021\/acs.jmedchem.8b00128","article-title":"Synthesis and biological evaluation of selenium-containing 4-anilinoquinazoline derivatives as novel antimitotic agents.","volume":"61","author":"An","year":"2018","journal-title":"J. Med. Chem."},{"key":"B2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1593\/neo.09154","article-title":"Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.","volume":"11","author":"Baba","year":"2009","journal-title":"Neoplasia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1021\/ml200156t","article-title":"Identification of NVP-BKM120 as a potent, selective, orally bioavailable class I PI3 kinase inhibitor for treating cancer.","volume":"2","author":"Burger","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces.","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discov."},{"key":"B5","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1158\/0008-5472.CAN-05-2519","article-title":"Role of hypoxia-inducible factor (HIF)-1\u03b1 versus HIF-2\u03b1 in the regulation of HIF target Genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.","volume":"66","author":"Carroll","year":"2006","journal-title":"Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jneumeth.2008.10.006","article-title":"EdU, a new thymidine analogue for labelling proliferating cells in the nervous system.","volume":"177","author":"Chehrehasa","year":"2009","journal-title":"J. Neurosci. Methods"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1074\/jbc.M709147200","article-title":"Redox-dependent changes in molecular properties of mitochondrial apoptosis-inducing factor.","volume":"283","author":"Churbanova","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/1235","article-title":"Pten is essential for embryonic development and tumour suppression.","volume":"19","author":"Cristofano","year":"1998","journal-title":"Nat. Genet."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-356","article-title":"Up-regulation and subcellular localization of hnRNP A2\/B1 in the development of hepatocellular carcinoma.","volume":"10","author":"Cui","year":"2010","journal-title":"BMC Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.drudis.2012.08.008","article-title":"High-content multiplexed tissue imaging and quantification for cancer drug discovery.","volume":"18","author":"Falcon","year":"2013","journal-title":"Drug Discov. Today"},{"key":"B11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1126\/science.7123245","article-title":"Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication.","volume":"218","author":"Gratzner","year":"1982","journal-title":"Science"},{"key":"B12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/2212697X04666170321112629","article-title":"The PI3K\/AKT\/mTOR-signal transduction pathway as drug target in triple-negative breast cancer.","volume":"4","author":"Hahne","year":"2017","journal-title":"Clin. Cancer Drugs"},{"key":"B13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer.","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1535-7163.mct-07-0067","article-title":"A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia.","volume":"6","author":"Ikezoe","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbrc.2016.09.169","article-title":"A morphological identification cell cytotoxicity assay using cytoplasm-localized fluorescent probe (CLFP) to distinguish living and dead cells.","volume":"482","author":"Lai","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1158\/1078-0432.ccr-06-2775","article-title":"Predictive value of Aurora-A\/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy.","volume":"13","author":"Lassmann","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1369\/jhc.2009.954701","article-title":"Mitochondrial DNA (mtDNA) biogenesis: visualization and duel incorporation of BrdU and EdU into newly synthesized mtDNA in vitro.","volume":"58","author":"Lentz","year":"2010","journal-title":"J. Histochem. Cytochem."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp023","article-title":"A rapid non-radioactive technique for measurement of repair synthesis in primary human fibroblasts by incorporation of ethynyl deoxyuridine (EdU).","volume":"37","author":"Limsirichaikul","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mce.2011.09.043","article-title":"Xenograft models for preclinical drug testing: implications for adrenocortical cancer.","volume":"351","author":"Luconi","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: an updated review.","volume":"46","author":"Martini","year":"2014","journal-title":"Ann. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1039\/c4cc06762b","article-title":"Development of 3-alkyl-6-methoxy-7-hydroxy-chromones (AMHCs) from natural isoflavones, a new class of fluorescent scaffolds for biological imaging.","volume":"51","author":"Miao","year":"2015","journal-title":"Chem. Commun."},{"key":"B23","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.4049\/jimmunol.121.6.2228","article-title":"Autoantibody to a nuclear antigen in proliferating cells.","volume":"121","author":"Miyachi","year":"1978","journal-title":"J. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2217\/bmm.15.85","article-title":"Cancer stem cell markers: premises and prospects.","volume":"9","author":"Murar","year":"2015","journal-title":"Biomark. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1177\/002215540305101212","article-title":"Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA.","volume":"51","author":"Muskhelishvili","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"20404","DOI":"10.1073\/pnas.1101126108","article-title":"Dynamic metabolic labeling of DNA in vivo with arabinosyl nucleosides.","volume":"108","author":"Neef","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1002\/cbic.201200253","article-title":"Metabolic labeling of DNA by purine analogues in vivo.","volume":"13","author":"Neef","year":"2012","journal-title":"ChemBioChem"},{"key":"B28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1535-6108(03)00085-0","article-title":"Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.","volume":"3","author":"Pennacchietti","year":"2003","journal-title":"Cancer Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1634\/theoncologist.11-8-868","article-title":"Molecular classification of breast cancer: limitations and potential.","volume":"11","author":"Pusztai","year":"2006","journal-title":"Oncologist"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9168","DOI":"10.1002\/anie.201403580","article-title":"Alkene\u2013Tetrazine ligation for imaging cellular DNA.","volume":"53","author":"Rieder","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1073\/pnas.0712168105","article-title":"A chemical method for fast and sensitive detection of DNA synthesis in vivo.","volume":"105","author":"Salic","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1016\/j.ddtec.2012.07.004","article-title":"Modeling of human tumor xenografts and dose rationale in oncology.","volume":"10","author":"Simeoni","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"B33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0960-9822(07)00488-5","article-title":"High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.","volume":"8","author":"Suzuki","year":"1998","journal-title":"Curr. Biol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer.","volume":"30","author":"Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nmeth741","article-title":"Stem cell proliferative history in tissue revealed by temporal halogenated thymidine analog discrimination.","volume":"2","author":"Vega","year":"2005","journal-title":"Nat. Methods"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23010154","article-title":"A mild aqueous sonogashira reaction as a fluorescent labeling strategy for 5-bromide-2\u2032-deoxyuridine.","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"B37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1535-7163.233.3.3","article-title":"Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.","volume":"3","author":"Welsh","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/cyto.a.20397","article-title":"A practical method to determine the amount of tissue to analyze using laser scanning cytometry.","author":"Wijsman","year":"2007","journal-title":"Cytometry A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1039\/C7AN01934C","article-title":"A Suzuki-Miyaura method for labelling proliferating cells containing incorporated BrdU.","volume":"143","author":"Yan","year":"2018","journal-title":"Analyst"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1016\/j.bmc.2016.09.049","article-title":"Synthesis and Pin1 inhibitory activity of thiazole derivatives.","volume":"24","author":"Zhao","year":"2016","journal-title":"Bioorg. Med. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00812\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T23:21:40Z","timestamp":1693783300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00812\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":40,"alternative-id":["10.3389\/fphar.2018.00812"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00812","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,25]]},"article-number":"812"}}